Cargando…
Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis
Today it is known that severe burns can be accompanied by the phenomenon of vasoplegic syndrome (VS), which is manifested by persistent and diffuse vasodilation, hypotension and low vascular resistance, resulting in circulatory and respiratory failure. The decrease in systemic vascular resistance ob...
Autores principales: | Farina, Jayme A., Celotto, Andrea Carla, da Silva, Marcelo Felix, Evora, Paulo Roberto B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560617/ https://www.ncbi.nlm.nih.gov/pubmed/22534716 http://dx.doi.org/10.12659/MSM.882718 |
Ejemplares similares
-
Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment
por: Barbosa Evora, Paulo Roberto
Publicado: (2018) -
Molecular docking analysis of phytoconstituent from Momordica charantia with Guanylate Cyclase catalytic domain
por: Ghanta, Mohankrishna, et al.
Publicado: (2018) -
The Use of Methylene Blue during Liver Transplantation for Vasoplegia
por: Harding, Paul, et al.
Publicado: (2021) -
Vasoplegia during radical prostatectomy: Methylene blue to rescue
por: Manish, Tandon, et al.
Publicado: (2023) -
Rapid reversal of vasoplegia with methylene blue in calcium channel blocker poisoning
por: Saha, Biplab K., et al.
Publicado: (2020)